88
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease

&
Pages 341-343 | Published online: 17 Sep 2007

Bibliography

  • BRANCACCIO D, COZZOLINO M: The mechanism of calcium deposition in soft tissues. Contrib. Nephrol. (2005) 149:279-286.
  • BRAUN J, OLDENDORF M, MOSHAGE W et al.: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am. J. Kidney Dis. (1996) 27:394-401.
  • London GM: Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J. Am. Soc. Nephrol. (2003) 14:S305-S309.
  • SCHWARTZ U, BUZZELLO M, RITZ E et al.: Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol. Dial. Transplant. (2000) 15:218-223.
  • COZZOLINO M, DUSSO A, SLATOPOLSKY E: Role of calcium × phosphate product and bone associated proteins on vascular calcification in renal failure. J. Am. Soc. Nephrol. (2001) 12:511-2516.
  • COZZOLINO M, BRANCACCIO D, GALLIENI M, SLATOPOLSKY E: Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int. (2005) 68(2):429-436.
  • GOODMAN WG, GOLDIN J, KUIZON BD et al.: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. NEJM (2000) 342:478-1483.
  • JONO S, MCKEE MD, MURRY CE et al.: Phosphate regulation of vascular smooth muscle cell calcification. Circ. Res. (2000) 87(7):E10-E17.
  • CHERTOW GM, BURKE SK, RAGGI P et al.: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. (2002) 62:245-252.
  • Bellinghieri G, SANTORO D, SAVICA V: Emerging drugs for hyperphosphatemia. Expert Opin. Emerging Drugs (2007) 12(3):355-365.
  • KAJBAF S, VEINOT JP, HA A, ZIMMERMAN D: Comparison of surgically removed cardiac valves of patients with ESRD with those of the general population. Am. J. Kidney Dis. (2005) 46:86-93.
  • COZZOLINO M, BRANCACCIO D: Hyperphosphatemia in dialysis patients: the therapeutic role of lanthanum carbonate. Int. J. Artif. Organs (2007) 30(4):293-300.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.